Integrated Patient Management System for the Improved Treatment of Asthma and Oth

描述（由申请人提供）：哮喘越来越常见和昂贵。目前估计美国哮喘患者人数超过2500万。哮喘占美国所有急诊室就诊的四分之一。在美国，直接治疗和间接患者费用从2002年的530亿美元上升到2007年的560亿美元。在全球范围内，估计有3亿人患有哮喘，患病率每十年增加50%，估计每年的费用超过1000亿美元。 目前存在有效的治疗方法来控制哮喘，但这种疾病诊断不足，治疗不足，药物依从性差。哮喘的专科护理可以改善结果并降低成本，但哮喘专家太少，无法管理所有哮喘患者。准确评估哮喘需要有关症状、药物使用和客观肺功能测量（肺功能测定）的具体信息。这些组成部分共同提供了必要的信息，以评估哮喘严重程度和哮喘控制，如国家哮喘教育和预防计划（NAEPP）指南所推荐的，其中将这些组成部分描述为“损害”和“风险”。准确评估严重程度和控制对于从NAEPP指南中阐述的治疗步骤中选择适当的治疗至关重要。 根据目前的指南和最佳实践，哮喘护理管理主要是基于医生提供的哮喘行动计划的患者自我管理。专家通常会提供这种服务，但其他医生可能不会。由于哮喘专家不关心大多数哮喘患者，其他医生和医生扩展需要解决方案，以帮助他们评估和适当管理哮喘。与此同时，根据《平价医疗法》，大量患者涌入医疗保健系统，需要重新定义医生办公室或诊所以外的护理点，以包括患者所在的任何地方（家庭、工作、休闲活动等）。 目前，还没有移动的、价格合理的产品能够为临床医生和患者提供所有的 哮喘评估和指导治疗选择的关键组成部分，使忙碌的通才和患者能够遵循临床最佳实践，在指南中阐述。我们的解决方案是一个集成系统，使用新技术为非专业临床医生和患者提供准确评估哮喘的工具，并指导根据NAEPP指南制定哮喘行动计划。如果成功，该范例将扩展到其他慢性呼吸系统疾病，如慢性阻塞性肺疾病，囊性纤维化和肺移植。

DESCRIPTION (provided by applicant): Asthma is increasingly common and expensive. Current estimates place the number of people in the US with asthma at over 25M. Asthma accounts for one-quarter of all emergency room visits in the US. Direct treatment and indirect patient costs rose from $53B in 2002 to $56B in 2007 in the US. Globally, 300M people are estimated to have asthma with prevalence increasing 50% per decade and estimated costs over $100B per year. Proven effective treatments exist to control asthma but the disease is under-diagnosed, undertreated and adherence to medication is poor. Specialty care for asthma leads to improved outcomes and lower costs but there are too few asthma specialists to manage all asthmatics. Accurate assessment of asthma requires specific information about symptoms, medication use and objective lung function measurements (spirometry). Together these components provide the necessary information to evaluate asthma severity and asthma control as recommended by National Asthma Education and Prevention Program (NAEPP) guidelines, which describes these components as "impairment" and "risk". Accurate assessment of severity and control is critical to appropriate treatment choices from among the treatment steps articulated in the NAEPP guidelines. Under the current guidelines and best practices, asthma care management is primarily patient self- management based upon an asthma action plan provided by the physician. Specialists usually provide this but other physicians may not. As asthma specialists do not care for most asthmatics, other physicians and physician extenders need solutions to help them assess and manage asthma appropriately. At the same time, the influx of patients into the health care system under the Affordable Care Act necessitates a re-definition of point-of-care beyond the physician's office or clinic to include wherever the patient happens to be (home, work, leisure activities, etc.). Currently there is no mobile, affordable product that provides clinicians and patients with all the key components of asthma assessment and guides treatment choices enabling busy generalists and patients to follow clinical best practices are articulated in the guidelines. Our solution is a integrated system using novel technologies to provide both the non-specialist clinician and the patient with the tools to assess asthma accurately and guidance on developing an asthma action plan based on NAEPP guidelines. If successful, the paradigm will be expanded to other chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis and lung transplant.